TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA). This marks a significant milestone in feline cardiac care as the...
Spotlight on CHASE This Spotlight Series focuses on The CHASE Study - a multicenter clinical trial using the Chiari-like Malformation & Syringomyelia Evaluation (CHASE)...